Literature DB >> 12842985

Tec regulates platelet activation by GPVI in the absence of Btk.

Ben T Atkinson1, Wilfried Ellmeier, Steve P Watson.   

Abstract

The Tec family kinase Btk plays an important role in the regulation of phospholipase C gamma 2 (PLC gamma 2) downstream of the collagen receptor glycoprotein VI (GPVI) in human platelets. Platelets also express a second member of this family, Tec; however, its function has not been analyzed. To address the role of Tec, we analyzed Btk-/-, Tec-/-, and Btk/Tec double-deficient (Btk-/-/Tec-/-) platelets. Tec-/- platelets exhibit a minor reduction in aggregation to threshold concentrations of collagen or the GPVI-specific agonist collagen-related peptide (CRP), whereas responses to higher concentrations are normal. Tyrosine phosphorylation of PLC gamma 2 by collagen and CRP is not altered in Tec-/- platelets. However, Btk-/-/Tec-/- platelets exhibit a greater reduction in PLC gamma 2 phosphorylation than is seen in the absence of Btk, thus revealing an important role for Tec in this situation. Furthermore, Btk-/-/Tec-/- platelets fail to undergo an increase in Ca2+, aggregation, secretion, and spreading in response to collagen or CRP, whereas they aggregate normally to adenosine diphosphate (ADP) and spread on fibrinogen. A residual GPVI signal exists in the Btk-/-/Tec-/- platelets as CRP synergizes with ADP to mediate aggregation. These results demonstrate an essential requirement for Tec and Btk in platelet activation by GPVI and reveal a functional role for Tec in the regulation of PLC gamma 2 in the absence of Btk.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842985     DOI: 10.1182/blood-2003-04-1142

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

1.  Laminin stimulates spreading of platelets through integrin alpha6beta1-dependent activation of GPVI.

Authors:  Osamu Inoue; Katsue Suzuki-Inoue; Owen J T McCarty; Masaaki Moroi; Zaverio M Ruggeri; Thomas J Kunicki; Yukio Ozaki; Steve P Watson
Journal:  Blood       Date:  2005-10-11       Impact factor: 22.113

2.  Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.

Authors:  Bhanu Kanth Manne; Rachit Badolia; Carol Dangelmaier; Johannes A Eble; Wilfried Ellmeier; Mark Kahn; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2015-03-12       Impact factor: 5.157

Review 3.  New Concepts and Mechanisms of Platelet Activation Signaling.

Authors:  Brian Estevez; Xiaoping Du
Journal:  Physiology (Bethesda)       Date:  2017-03

4.  Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI.

Authors:  Phillip L R Nicolson; Craig E Hughes; Stephanie Watson; Sophie H Nock; Alexander T Hardy; Callum N Watson; Samantha J Montague; Hayley Clifford; Aarnoud P Huissoon; Jean-Daniel Malcor; Mark R Thomas; Alice Y Pollitt; Michael G Tomlinson; Guy Pratt; Steve P Watson
Journal:  Haematologica       Date:  2018-07-19       Impact factor: 9.941

Review 5.  Ibrutinib-associated bleeding: pathogenesis, management and risk reduction strategies.

Authors:  J J Shatzel; S R Olson; D L Tao; O J T McCarty; A V Danilov; T G DeLoughery
Journal:  J Thromb Haemost       Date:  2017-03-27       Impact factor: 5.824

6.  Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1.

Authors:  Benjamin E Tourdot; Michelle K Brenner; Kathleen C Keough; Trudy Holyst; Peter J Newman; Debra K Newman
Journal:  Biochemistry       Date:  2013-04-03       Impact factor: 3.162

Review 7.  Targeting B Cell Signaling in Chronic Lymphocytic Leukemia.

Authors:  Jon E Arnason; Jennifer R Brown
Journal:  Curr Oncol Rep       Date:  2017-09       Impact factor: 5.075

8.  Reactive oxygen species play a critical role in collagen-induced platelet activation via SHP-2 oxidation.

Authors:  Ji Yong Jang; Ji Hyun Min; Yun Hee Chae; Jin Young Baek; Su Bin Wang; Su Jin Park; Goo Taeg Oh; Sang-Hak Lee; Ye-Shih Ho; Tong-Shin Chang
Journal:  Antioxid Redox Signal       Date:  2014-01-30       Impact factor: 8.401

9.  Glycoproteins VI and Ib-IX-V stimulate tyrosine phosphorylation of tyrosine kinase Syk and phospholipase Cgamma2 at distinct sites.

Authors:  Katsue Suzuki-Inoue; Jonathan I Wilde; Robert K Andrews; Jocelyn M Auger; Reuben P Siraganian; Fujio Sekiya; Sue Goo Rhee; Steve P Watson
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

10.  Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI-mediated platelet function.

Authors:  Rachel A Rigg; Joseph E Aslan; Laura D Healy; Michael Wallisch; Marisa L D Thierheimer; Cassandra P Loren; Jiaqing Pang; Monica T Hinds; András Gruber; Owen J T McCarty
Journal:  Am J Physiol Cell Physiol       Date:  2015-12-09       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.